ESTRO 35 Programme book

LIFETIME ACHIEVEMENT

MICHAEL BRADA University of Liverpool & Clatterbridge Cancer Centre Liverpool, UK

Michael Brada FRCP FRCR DSc is a Professor of Radiation Oncology at the University of Liverpool and Clatterbridge Cancer Centre; previously at the Royal Marsden Hospital, London. A leading expert in neuro-oncology and thoracic oncology and author and co-author of more than 250 peer-reviewed articles, editorials and book chapters. As the President of ESTRO (2003-2005) he restored the focus on education; as the President of EANO (European Association of Neuro-oncology) nurtured a young organisation towards the principal European force it is now. He has been a leader in the development of radiotherapy in neuro- oncology, with benchmark studies of technical aspects and clinical outcome of stereotactic radiotherapy and key studies of late toxicity of cranial irradiation. He made a major contribution to chemotherapy and radiotherapy in glial tumours and brain metastases. In lung cancer he developed and tested novel technologies including motion management techniques and high precision irradiation. Throughout his career has been a passionate believer in evidence based medicine. He has a deep interest in improving care and developing and testing novel methods of follow-up. His studies have resulted in widespread changes to clinical practice. His interest in evaluation of novel technologies through systematic reviews and meta-analyses focusing on benefit to patients have generated heated debates and continue to irritate “believers” in technical innovation as a sufficient goal for the future of radiotherapy.

Michael Brada

AWARDS | PROGRAMME AND EXHIBITION GUIDE

28